GlassScriptPhysician profile
James Andrew Miller
NPI 1346300019
$7,442.09
in general payments reported to CMS, 2019-2025
11 companies · $821 in 2025
The $821 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $178 · 2023: $2,273 · 2024: $4,170 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,021 · Travel and Lodging: $3,014 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,020.87 |
| Travel and Lodging | $3,014.43 |
| Education | $229.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,969.62 | 2023-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Atricure, INC. | $1,111.74 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $538.87 | 2022-2023 | Mosaic |
| Zimmer Biomet Holdings, INC. | $398.70 | 2024-2025 | Sternalock, Ribfix Blu Advantage |
| Kci USA, INC. | $120.70 | 2023 | Prevena, V.A.C. Veraflo |
| Foundation Medical, LLC | $104.97 | 2025 | |
| Getinge USA Sales, LLC | $75.72 | 2025 | Vasoview Hemopro 2 |
| Artivion, INC. | $52.13 | 2024-2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Abiomed | $36.25 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.99 | 2024 | Jardiance |
| Ethicon US, LLC | $15.40 | 2025 | Stratafix, Evarrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.